Management Name : Air Chief Marshal SURASAK MEEMANEE | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 17/01/2018
increased in revenues from sales of medicated pet shampoo, pet foods products, livestock animal products, and revenues from sales of wellness & anti-aging products and aesthetic innovations products. 2. Cost
shares of WCI Holding PCL, held by EFORL. As coronavirus situation may impact to the business which is unable to be expected, the Board of Director meeting considers that the investment in wellness
growth was driven primarily by an increase in revenues from sales of pet skincare shampoo products, pet food products and livestock animal products, and revenues from sales of wellness & anti-ageing
Thai ESG funds. The initiative is expected to raise the public awareness of long-term savings to promote financial wellness and drive Thailand towards sustainable development. For more details
% MB % MB % 1. Wellness and Anti-aging 128.58 40.58% 162.70 43.82% 34.12 26.54% 2. Aesthetic Innovation 96.00 30.30% 67.17 18.09% (28.83) (30.03%) 3. Companion Animal Health 80.78 25.50% 132.19 35.60
-634-0225 Fax 02-634-0135 www.interpharma.co.th Type of Revenue 1st Quarter 2020 1st Quarter 2019 Change MB % MB % MB % 1. Wellness & Anti-Aging 47.77 49.18 31.87 37.52 15.90 49.90% 2. Aesthetic
Mr. Yannakorn Warakunrak Mr. Yannakorn Warakunrak, the Chief Executive Officer, responsible for the operation of the Polaris Capital Public Company Limited (“POLAR”), shall be liable for POLAR’s